Skip to main content

Schlesinger Michael A.'s Form 4 filing

Ortho Clinical Diagnostics Holdings plc (OCDX) · filed Aug 13, 2021

Accession no.
0001209191-21-051446
Filed
Aug 13, 2021
Trade date
Aug 11-13, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.68M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schlesinger Michael A.CIK 0001839441Officer (EVP, GC and Secretary)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 11, 2021Ordinary Shares, $0.00001 par valueMOption exerciseAcquired+72,585$6.28+$455,833.8160,222Direct
Aug 11, 2021Ordinary Shares, $0.00001 par valueSSaleDisposed−72,585$19.76F2,F3−$1,434,279.687,637Direct
Aug 12, 2021Ordinary Shares, $0.00001 par valueMOption exerciseAcquired+8,100$6.28+$50,86895,737Direct
Aug 12, 2021Ordinary Shares, $0.00001 par valueSSaleDisposed−8,100$20.00F2,F4−$162,00087,637Direct
Aug 13, 2021Ordinary Shares, $0.00001 par valueMOption exerciseAcquired+4,300$6.28+$27,00491,937Direct
Aug 13, 2021Ordinary Shares, $0.00001 par valueSSaleDisposed−4,300$20.00F2,F5−$86,00087,637Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 11, 2021Ordinary Shares, $0.00001 par valueMOption exerciseDisposed−72,585$0.00$0350,922Direct
Aug 12, 2021Ordinary Shares, $0.00001 par valueMOption exerciseDisposed−8,100$0.00$0342,822Direct
Aug 13, 2021Ordinary Shares, $0.00001 par valueMOption exerciseDisposed−4,300$0.00$0338,522Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.

Referenced by the price of 3 transactions in Table I.

F3

Represents the weighted average sales price for the price increments ranging from $19.4800 to $20.0700.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0050.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0100.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)